Celcuity Inc. (CELC) Ownership

NASDAQ: CELCTop holders, insider trades and short interest.

CELC ownership summary

as of October 17, 2026
Institutions
112.7%
of shares outstanding
Insiders
10.23%
of shares outstanding
Shares outstanding
48.9M
Float
29.7M
shares available to trade
Short interest
33.66%
11.0M shares short
Days to cover
11.35
short interest down 3.4% vs prior month
  • Institutions 112.67%
  • Insiders 10.23%

CELC top institutional holders

20 largest
Celcuity Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Baker Bros Advisors LP16.18%7.9M$447.9M—June 30, 2026
2venBio Select Advisor LLC6.95%3.4M$192.4M+25,000 (+0.7%)June 30, 2026
3RTW INVESTMENTS, LLC6.75%3.3M$187.0M+265,282 (+8.7%)June 30, 2026
4Perceptive Advisors LLC6.53%3.2M$180.9M+70,000 (+2.2%)June 30, 2026
5BlackRock Inc6.17%3.0M$170.8M+307,253 (+11.3%)June 30, 2026
6State Street Corp4.00%2.0M$110.6M+436,599 (+28.7%)June 30, 2026
7Vanguard Capital Management, LLC3.83%1.9M$106.0M+91,243 (+5.1%)June 30, 2026
8NEA Management Company, LLC3.50%1.7M$96.8M−575,000 (−25.2%)June 30, 2026
9Soleus Capital Management, L.P.3.48%1.7M$96.4M+419,940 (+32.7%)June 30, 2026
10Bank of America Corp3.01%1.5M$83.2M+756,978 (+106.0%)June 30, 2026
11Deerfield Management Co2.97%1.5M$82.1M−262,986 (−15.3%)June 30, 2026
12Morgan Stanley - Brokerage Accounts2.73%1.3M$75.5M−11,170 (−0.8%)June 30, 2026
13TANG CAPITAL MANAGEMENT LLC2.69%1.3M$74.4M+264,594 (+25.2%)June 30, 2026
14The Toronto-Dominion Bank2.57%1.3M$71.2M+376,000 (+42.6%)June 30, 2026
15Geode Capital Management, LLC2.27%1.1M$62.9M+220,592 (+24.8%)June 30, 2026
16T. Rowe Price Associates, Inc.2.10%1.0M$58.0M−253,979 (−19.8%)June 30, 2026
17Wellington Management Company LLP1.85%907K$51.3M+477,643 (+111.4%)June 30, 2026
18The Goldman Sachs Group Inc1.78%870K$49.3M+105,474 (+13.8%)June 30, 2026
19Point72 Asset Management, L.P.1.33%651K$36.8M+370,592 (+132.2%)June 30, 2026
20Hood River Capital Management LLC1.28%628K$35.6M+628,411 (0.0%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 15 holders added 4.8M shares and 4 cut 1.1M.

CELC top mutual fund and ETF holders

20 largest
Celcuity Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest2.86%1.4M$79.1M−1,675 (−0.1%)August 31, 2026
2State Street® SPDR® S&P® Biotech ETF2.46%1.2M$68.2M−22,950 (−1.9%)September 30, 2026
3iShares Russell 2000 ETF2.04%996K$56.4M−11,456 (−1.1%)September 30, 2026
4Fidelity Select Biotechnology0.98%479K$27.1M—August 31, 2026
5Fidelity Small Cap Index0.86%421K$23.8M+3,538 (+0.8%)July 31, 2026
6iShares Russell 2000 Growth ETF0.74%360K$20.4M−455 (−0.1%)September 30, 2026
7American Century Small Cap Growth Inv0.69%339K$19.2M+339,390 (0.0%)June 30, 2026
8Artisan International Small-Mid Investor0.58%286K$16.2M+2,921 (+1.0%)June 30, 2026
9Hood River Small-Cap Growth Instl0.46%223K$12.6M+222,657 (0.0%)June 30, 2026
10Vanguard Russell 2000 ETF0.45%221K$12.5M+5,240 (+2.4%)August 31, 2026
11Schwab US Small-Cap ETF™0.44%216K$12.2M+144 (+0.1%)September 30, 2026
12Harbor Small Cap Growth Instl0.42%205K$11.6M+204,608 (0.0%)June 30, 2026
13Eventide Healthcare & Life Sciences I0.40%196K$11.1M−47,293 (−19.5%)June 30, 2026
14MEDICAL BioHealth EUR Acc0.38%187K$10.6M+40 (+0.0%)August 31, 2026
15Fidelity Extended Market Index0.38%186K$10.5M−980 (−0.5%)August 31, 2026
16T. Rowe Price Integrated US Sm Gr Eq0.37%179K$10.1M—August 31, 2026
17T. Rowe Price New Horizons0.36%176K$9.9M−22,047 (−11.2%)August 31, 2026
18Belfius Equities Cure C Cap0.34%169K$9.6M−133,504 (−44.2%)March 31, 2026
19Voya Small Cap Growth I0.34%165K$9.4M+1,551 (+0.9%)August 31, 2026
20AB Small Cap Growth A0.27%131K$7.4M−2,548 (−1.9%)August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

CELC insider transactions

latest 6
Celcuity Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-03-31Richard E BullerSell$110.273,000$330,810
2026-01-27David DalveySell$120.0320,000$2.4M
2025-12-05Richard E BullerSell$105.693,000$317,070
2025-11-20Richard E BullerSell$96.733,900$377,247
2025-07-28David DalveySell$45.129,325$420,744
2025-07-28David DalveySell$43.98100,000$4.4M

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

CELC shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns CELC

Institutional investors own 112.7% of Celcuity's shares and insiders 10.23%. The largest holder is Baker Bros Advisors LP with 16.18% of the shares (7.9M), as of June 30, 2026. Among the top 20 institutions, 15 added shares and 4 reduced their stake in the latest filings. Short interest is 33.66% of the float, or 11.35 days of average trading volume. The share count rose 775.7% since 2015.

Related: CELC analyst forecast, CELC key metrics. See the CELC stock overview for the latest quote and news.

CELC ownership FAQ

Who owns the most Celcuity stock?

The largest shareholders of Celcuity are Baker Bros Advisors LP (16.18%), venBio Select Advisor LLC (6.95%), RTW INVESTMENTS, LLC (6.75%), Perceptive Advisors LLC (6.53%), BlackRock Inc (6.17%).

What percentage of Celcuity is owned by institutions?

Institutions hold 112.7% of Celcuity's shares outstanding; insiders hold 10.23%.

Which funds own Celcuity?

The largest fund holders of Celcuity are Vanguard MStar Total Stk Mkt Idx Invest (2.86%), State Street® SPDR® S&P® Biotech ETF (2.46%), iShares Russell 2000 ETF (2.04%), Fidelity Select Biotechnology (0.98%), Fidelity Small Cap Index (0.86%).

What is Celcuity's short interest?

11.0M shares of Celcuity were sold short, 33.66% of the float; at the average daily volume it would take 11.35 days to cover.

Are insiders buying or selling Celcuity?

Of the latest 6 reported insider transactions in Celcuity (since July 28, 2025), 0 were purchases and 6 were sales.

How many shares of Celcuity are outstanding?

Celcuity has 48.9M shares outstanding, of which 29.7M are in the public float.

Biotechnology: ownership